On 18 July 2015, at the IAS 2015 pre-conference UN 90-90-90 Target workshop: lessons from the field, Gottfried Hirnschall, Director of HIV Department at World Health Organization (WHO) provided a "sneak preview" of the in-the-process-of-being-updated 2015 consolidated guidelines.
The headline is: following the START results, WHO will recommend ART for everyone with HIV.
Also important is that dolutegravir and efavirenz 400 mg will be recommended as alternatives first-line options to using efavirenz 600 mg.
This is good news.
Expect more sneak previews of the guidelines -- details are promised at IAS.
Hirnschall G. WHO Global HIV Guidelines: How innovations in policy and implementation can pave the way to achieving 90-90-90. UN 90-90-90 Target workshop: lessons from the field.18 July 2015. Vancouver, BC, Canada.